Australia markets closed

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
181.24-8.70 (-4.58%)
At close: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
778,770
670,534
366,260
270,245
194,032
Cost of revenue
326,159
279,280
156,634
119,099
86,531
Gross profit
452,611
391,254
209,626
151,146
107,501
Operating expenses
Research development
40,868
34,274
20,182
19,450
15,821
Selling general and administrative
209,379
183,866
119,621
95,613
65,692
Total operating expenses
250,247
218,140
139,803
115,063
81,513
Operating income or loss
202,364
173,114
69,823
36,083
25,988
Interest expense
7,736
12,714
12,133
9,292
6,709
Total other income/expenses net
335
-6,857
1,527
-640
2,157
Income before tax
194,767
153,543
59,217
26,151
21,436
Income tax expense
35,334
25,252
-709
4,740
4,819
Income from continuing operations
159,433
128,291
59,926
21,411
16,617
Net income
159,433
128,291
59,926
21,411
16,617
Net income available to common shareholders
159,433
128,291
59,926
21,411
16,617
Basic EPS
-
2.33
1.14
0.44
0.38
Diluted EPS
-
2.24
1.11
0.44
0.37
Basic average shares
-
55,015
52,554
48,343
43,767
Diluted average shares
-
57,264
53,892
49,206
45,471
EBITDA
-
204,704
98,417
56,311
43,923